The many facets of stone disease: a practical outlook on 24-hour urine and genetic testing

Neal Shore, MD, FACS, is a U.S. Chief Medical Officer at GenesisCare USA and Medical Director of the Carolina Urologic Research Center. He also was an investigator on the Phase 2 and 3 studies in the clinical trial program for nadofaragene firadenovec-vncg.

Dr. Michael Lipkin discusses a recent study conducted at Duke University Hospital that found that a new single-use cystoscope demonstrated superior flexion and comparable optics to the reusable scopes already being used in a hospital urology department.

When it comes to technology, recommendations from a peer can highlight which solution is best for your practice. Learn how this urology practice was transformed by implementing our ModMed® Urology EHR.